Target intelligence / Profile preview

Tubulin (TUB) (TUB)

Target
TUB
Molecular classification
Cytoskeletal protein, Structural protein
01

Overview

Tubulin is a highly conserved globular protein that functions as the structural subunit of microtubules, which are vital for maintaining cell shape, intracellular transport, and the formation of the mitotic spindle during cell division (UniProt P68363). It exists primarily as a heterodimer of alpha-tubulin and beta-tubulin subunits. In the context of oncology, tubulin is a critical therapeutic target; drugs like vincristine bind specifically to the vinca domain at the interface of tubulin dimers (StatPearls NBK519525). This binding prevents the polymerization of tubulin into microtubules, causing the disruption of the mitotic spindle and arresting the cell cycle in metaphase (PubMed PMC3136731). Consequently, this leads to the induction of apoptosis in rapidly dividing cancer cells, making it a cornerstone in the treatment of various leukemias, lymphomas, and solid tumors. Beyond its role in mitosis, tubulin is essential for neuronal structure and transport, which explains why drugs targeting it often result in neurotoxic side effects. Resistance to tubulin-binding agents can occur through the expression of specific tubulin isotypes, such as beta-III tubulin, which alter microtubule dynamics (PubMed PMC2671028). Overall, tubulin remains one of the most successful targets in clinical chemotherapy due to its fundamental role in cell proliferation.

Other names
Alpha-tubulinBeta-tubulinMicrotubule proteinVinca alkaloid binding siteTubulin heterodimer
02

Mechanism of action

Inhibition of microtubule polymerization by binding to the vinca domain of tubulin heterodimers, leading to mitotic arrest in metaphase and subsequent apoptosis (StatPearls NBK519525).

03

Biological functions

Cell cycleMitosisIntracellular transportCell motilityStructural support
04

Disease associations

CancerLeukemiaLymphomaSarcomaNeuroblastoma
05

Safety considerations

Peripheral neuropathy (PubMed PMC3136731)MyelosuppressionVesicant activity (tissue necrosis)Autonomic neuropathy (constipation)
06

Interacting drugs

Vincristine

4 more in the full profile.

07

Biomarkers

Beta-III tubulin (TUBB3) expression (PubMed PMC2671028)Mitotic indexMAP2 expression

Beyond the preview

Go deeper on Tubulin (TUB) (TUB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin (TUB) (TUB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call